Opportunities and challenges in applying microbiota to clinical cancer immunotherapy
Trends in Microbiology · 2026-04 · 34 (4) · 367-377
DOI: 10.1016/j.tim.2025.11.011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Microbiology, 2026-04. Verfasst von Dingjiacheng Jia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310058, China; Ins…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Fundamental research has elucidated the indispensable role of gut microbiota in modulating cancer immunotherapy efficacy. Despite promising preclinical findings, few related approaches have reached clinical trials. In this opinion, we provide insights based on current clinical trials using fecal microbiota transplant or specific bacterial strains as adjuvants to enhance immune checkpoint blockade therapy. We also systematically analyze the challenges in trial design, with a focus on donor selection, patient enrollment, implantation procedures, antibiotic use, safety assessment, and endpoint evaluation. Moving forward, we offer a comprehensive '4D' framework (diversity, diffusion, depth, and delicacy) for accelerating the bench-to-bedside translation. It is hoped that this opinion will help researchers and clinicians aiming to harness microbiome-based strategies to improve cancer immunotherapy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310058, China; Institution of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang…
Zitieren
APA
Jia, D., & Wang, L. (2026). Opportunities and challenges in applying microbiota to clinical cancer immunotherapy. Trends in Microbiology, 34(4), 367-377. https://doi.org/10.1016/j.tim.2025.11.011
Vancouver
Jia D, Wang L. Opportunities and challenges in applying microbiota to clinical cancer immunotherapy. Trends in Microbiology. 2026;34(4):367-377. doi:10.1016/j.tim.2025.11.011
BibTeX
@article{Jia2026,
author = {Jia, Dingjiacheng and Wang, Liangjing},
title = {Opportunities and challenges in applying microbiota to clinical cancer immunotherapy},
journal = {Trends in Microbiology},
year = {2026},
volume = {34},
number = {4},
pages = {367--377},
doi = {10.1016/j.tim.2025.11.011}
}
EUVIMED